Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring

Journal of Chromatography A

Volumn 1292, Issue , 2013, Pages 160-172

  Ansermot, Nicolas ^a   Brawand Amey, Marlyse ^a   Kottelat, Astrid ^a   Eap, Chin B ^a,b  

^a Hopital de Cery   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Antidepressants; Antipsychotics; Method validation; Protein precipitation; Therapeutic drug monitoring; UHPLC MS MS

Indexed keywords

ANTIDEPRESSANTS; ANTIPSYCHOTICS; METHOD VALIDATIONS; PROTEIN PRECIPITATION; THERAPEUTIC DRUG MONITORING; U-HPLC-MS;

ACETONITRILE; CHROMATOGRAPHY; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPES; LASERS; MASS SPECTROMETRY; METABOLITES; PATIENT MONITORING; PLASMA (HUMAN); PROTEINS;

DRUG PRODUCTS;

AMISULPRIDE; ASENAPINE; DESMETHYLMIRTAZAPINE; ILOPERIDONE; MIRTAZAPINE; NORQUETIAPINE; OLANZAPINE; PALIPERIDONE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD ANALYSIS; CALIBRATION; DRUG MONITORING; HUMAN; ISOTOPE LABELING; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; PSYCHOTROPIC DRUGS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84877143802     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2012.12.071     Document Type: Article

References (52)

1. Freedman R. N. Engl. J. Med. 2003, 349:1738.
2. Lehman A.F., Lieberman J.A., Dixon L.B., McGlashan T.H., Miller A.L., Perkins D.O., Kreyenbuhl J. Am. J. Psychiatry 2004, 161:1.
3. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Lancet 2009, 373:31.
4. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K., I. N. Engl. J. Med. 2005, 353:1209.
5. Jones P.B., Barnes T.R., Davies L., Dunn G., Lloyd H., Hayhurst K.P., Murray R.M., Markwick A., Lewis S.W. Arch. Gen. Psychiatry 2006, 63:1079.
6. Gelenberg A.J. J. Clin. Psychiatry 2010, 71:e06.
7. De Boer T. Int. Clin. Psychopharmacol. 1995, 10(Suppl. 4):19.
8. Sheehan J.J., Sliwa J.K., Amatniek J.C., Grinspan A., Canuso C.M. Curr. Drug Metab. 2010, 11:516.
9. Crisafulli C., Fabbri C., Porcelli S., Drago A., Spina E., De Ronchi D., Serretti A. Front. Pharmacol. 2011, 2:1.
10. Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Grunder G., Haen E., Havemann-Reinecke U., Jaquenoud Sirot E., Kirchherr H., Laux G., Lutz U.C., Messer T., Muller M.J., Pfuhlmann B., Rambeck B., Riederer P., Schoppek B., Stingl J., Uhr M., Ulrich S., Waschgler R., Zernig G. Pharmacopsychiatry 2011, 44:195.
11. Prieto E., Mico J.A., Meana J.J., Majadas S. Actas Esp. Psiquiatr. 2010, 38:22.
12. Lind A.B., Reis M., Bengtsson F., Jonzier-Perey M., Powell Golay K., Ahlner J., Baumann P., Dahl M.L. Clin. Pharmacokinet. 2009, 48:63.
13. Wille S.M.R., Van Hee P., Neels H.M., Van Peteghem C.H., Lambert W.E. J. Chromatogr. A 2007, 1176:236.
14. Wille S.M.R., De Letter E.A., Piette M.H., Van Overschelde L.K., Van Peteghem C.H., Lambert W.E. Int. J. Legal Med. 2009, 123:451.
15. Ascalone V., Ripamonti M., Malavasi B. J. Chromatogr. B 1996, 676:95.
16. Sachse J., Koller J., Hartter S., Hiemke C. J. Chromatogr. B 2006, 830:342.
17. Mercolini L., Grillo M., Bartoletti C., Boncompagni G., Raggi M.A. Anal. Bioanal. Chem. 2007, 388:235.
18. Mutlib A.E., Strupczewski J.T. J. Chromatogr. B 1995, 669:237.
19. Kratzsch C., Peters F.T., Kraemer T., Weber A.A., Maurer H.H. J. Mass Spectrom. 2003, 38:283-295.
20. Choong E., Rudaz S., Kottelat A., Guillarme D., Veuthey J.L., Eap C.B. J. Pharm. Biomed. Anal. 2009, 50:1000.
21. Gschwend M.H., Arnold P., Ring J., Martin W. J. Chromatogr. B 2006, 831:132.
22. Nirogi R., Bhyrapuneni G., Kandikere V., Mudigonda K., Ajjala D., Suraneni R., Mukkanti K. Biomed. Chromatogr. 2008, 22:1424.
23. Roman M., Kronstrand R., Lindstedt D., Josefsson M. J. Anal. Toxicol. 2008, 32:147.
24. Davis P.C., Bravo O., Gehrke M., Azumaya C.T. J. Pharm. Biomed. Anal. 2010, 51:1113.
25. Couchman L., Morgan P.E., Flanagan R.J. Biomed. Chromatogr. 2011, 25:867.
26. Saar E., Gerostamoulos D., Drummer O.H., Beyer J. J. Mass Spectrom. 2010, 45:915.
27. Mogili R., Kanala K., Challa B.R., Chandu B.R., Bannoth C.K. Sci. Pharm. 2011, 79:583.
28. Pan R.N., Kuo B.P., Pao L.H. J. Chromatogr. Sci. 2012, 50:277.
29. de Boer T., Meulman E., Meijering H., Wieling J., Dogterom P., Lass H. Biomed. Chromatogr. 2012, 26:156.
30. Berna M., Shugert R., Mullen J. J. Mass Spectrom. 1998, 33:1003.
31. Kollroser M., Schober C. Rapid Commun. Mass Spectrom. 2002, 16:1266.
32. Nielsen M.K., Johansen S.S. J. Anal. Toxicol. 2009, 33:212.
33. Bhatt J., Subbaiah G., Singh S. Rapid Commun. Mass Spectrom. 2006, 20:2109.
34. Kirchherr H., Kuhn-Velten W.N. J. Chromatogr. B 2006, 843:100.
35. Guillarme D., Ruta J., Rudaz S., Veuthey J.L. Anal. Bioanal. Chem. 2010, 397:1069.
36. del Mar Ramirez Fernandez M., Wille S.M., Samyn N. Ther. Drug Monit. 2012, 34:11.
37. Hasselstrom J. J. Chromatogr. B 2011, 879:123.
38. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. AAPS J. 2007, 9:E30.
39. FDA, Guidance for Industry: Bioanalytical Method Validation. 2001 (last access May 2012). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
40. European Medicines Agency, Guideline on Bioanalytical Method Validation. 2011 (last access May 2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
41. Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., Hubert P. J. Chromatogr. A 2007, 1158:111.
42. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuizet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. STP Pharma. Pract. 2003, 13:101.
43. Bonfiglio R., King R.C., Olah T.V., Merkle K. Rapid Commun. Mass Spectrom. 1999, 13:1175.
44. Souverain S., Rudaz S., Veuthey J.L. J. Chromatogr. A 2004, 1058:61.
45. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
46. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., Chiap P., Grandjean D., Hubert P., Lagorce P., Lallier M., Laparra M.C., Laurentie M., Nivet J.C. STP Pharma. Pract. 1997, 7:169.
47. Choong E., Rudaz S., Kottelat A., Haldemann S., Guillarme D., Veuthey J.L., Eap C.B. J. Chromatogr. B 2011, 879:1544.
48. Noetzli M., Choong E., Ansermot N., Eap C.B. Ther. Drug Monit. 2011, 33:227.
49. Ansermot N., Brawand-Amey M., Eap C.B. J. Chromatogr. B 2012, 885-886:117.
50. Polson C., Sarkar P., Incledon B., Raguvaran V., Grant R. J. Chromatogr. B 2003, 785:263.
51. Noetzli M., Ansermot N., Dobrinas M., Eap C.B. J. Pharm. Biomed. Anal. 2012, 64-65:16.
52. Marchi I., Rudaz S., Selman M., Veuthey J.L. J. Chromatogr. B 2007, 845:244.